Overall, while mutational burden (TMB and mutation count) appeared similar between ethnic groups, H/L patients exhibited a trend toward higher chromosomal instability (FGA) and a significantly increased frequency of FGFR4 mutations, which may contribute to ethnic-specific differences in HCC progression, prognosis, and therapeutic response. This evidence concerns the gene FGFR4 and hepatocellular carcinoma.